caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1548333297

Mishaela RubinM.D.

EndocrinologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Mishaela Rubin's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
THE NEW YORK AND PRESBYTERIAN HOSPITAL81177
Marcella Walker
Endocrinology · New York, NY
2128
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
85.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$3K
Payment records
3
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$3K
Food and Beverage$173
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
707
Unique beneficiaries
—
Total services
735
Distinct HCPCS
3
Medicare payment
$41K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 627 Endocrinology providers in NY — below median (cohort median 837).
PRESCRIBING · PART D · 2024
Total Rx claims
259
Beneficiaries
—
Total drug cost
$156K
Distinct drugs
6
Brand share
9.3%
Top prescribed drugs
Alendronate Sodium84 claims
Risedronate Sodium45 claims
Calcitriol38 claims
Levothyroxine Sodium38 claims
Teriparatide24 claims